A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.
- Published In:
- Expert opinion on pharmacotherapy, 25(5), 611-619 (2024)
- Authors:
- Bikou, Alexia, Dermiki-Gkana, Foteini, Penteris, Michail, Constantinides, Theodoros K, Kontogiorgis, Christos
- Database ID:
- RPEP-07858
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07858APA
Bikou, Alexia; Dermiki-Gkana, Foteini; Penteris, Michail; Constantinides, Theodoros K; Kontogiorgis, Christos. (2024). A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.. Expert opinion on pharmacotherapy, 25(5), 611-619. https://doi.org/10.1080/14656566.2024.2343092
MLA
Bikou, Alexia, et al. "A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.." Expert opinion on pharmacotherapy, 2024. https://doi.org/10.1080/14656566.2024.2343092
RethinkPeptides
RethinkPeptides Research Database. "A systematic review of the effect of semaglutide on lean mas..." RPEP-07858. Retrieved from https://rethinkpeptides.com/research/bikou-2024-a-systematic-review-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.